Global Japanese Encephalitis Virus Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 110169
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Japanese Encephalitis Virus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Japanese Encephalitis Virus Vaccine market size is estimated to be worth US$ 214.6 million in 2021 and is forecast to a readjusted size of USD 302.4 million by 2028 with a CAGR of 5.0% during review period. Public accounting for % of the Japanese Encephalitis Virus Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Inactivated Vaccine segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Japanese Encephalitis Virus Vaccine include Research Foundation for Microbial Diseases of Osaka University, Valneva Austria GmbH, Chengdu Institute, Liaoning Dacheng, and Wuhan Institute, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Japanese Encephalitis Virus Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Inactivated Vaccine

Live Attenuated Vaccine

Market segment by Application can be divided into

Public

Private

The key market players for global Japanese Encephalitis Virus Vaccine market are listed below:

Research Foundation for Microbial Diseases of Osaka University

Valneva Austria GmbH

Chengdu Institute

Liaoning Dacheng

Wuhan Institute

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Japanese Encephalitis Virus Vaccine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Japanese Encephalitis Virus Vaccine, with price, sales, revenue and global market share of Japanese Encephalitis Virus Vaccine from 2019 to 2022.

Chapter 3, the Japanese Encephalitis Virus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Japanese Encephalitis Virus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Japanese Encephalitis Virus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Japanese Encephalitis Virus Vaccine.

Chapter 13, 14, and 15, to describe Japanese Encephalitis Virus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Japanese Encephalitis Virus Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Japanese Encephalitis Virus Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 Inactivated Vaccine

1.2.3 Live Attenuated Vaccine

1.3 Market Analysis by Application

1.3.1 Overview: Global Japanese Encephalitis Virus Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Public

1.3.3 Private

1.4 Global Japanese Encephalitis Virus Vaccine Market Size & Forecast

1.4.1 Global Japanese Encephalitis Virus Vaccine Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Japanese Encephalitis Virus Vaccine Sales in Volume (2017-2028)

1.4.3 Global Japanese Encephalitis Virus Vaccine Price (2017-2028)

1.5 Global Japanese Encephalitis Virus Vaccine Production Capacity Analysis

1.5.1 Global Japanese Encephalitis Virus Vaccine Total Production Capacity (2017-2028)

1.5.2 Global Japanese Encephalitis Virus Vaccine Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Japanese Encephalitis Virus Vaccine Market Drivers

1.6.2 Japanese Encephalitis Virus Vaccine Market Restraints

1.6.3 Japanese Encephalitis Virus Vaccine Trends Analysis

2 Manufacturers Profiles

2.1 Research Foundation for Microbial Diseases of Osaka University

2.1.1 Research Foundation for Microbial Diseases of Osaka University Details

2.1.2 Research Foundation for Microbial Diseases of Osaka University Major Business

2.1.3 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product and Services

2.1.4 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 Valneva Austria GmbH

2.2.1 Valneva Austria GmbH Details

2.2.2 Valneva Austria GmbH Major Business

2.2.3 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product and Services

2.2.4 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 Chengdu Institute

2.3.1 Chengdu Institute Details

2.3.2 Chengdu Institute Major Business

2.3.3 Chengdu Institute Japanese Encephalitis Virus Vaccine Product and Services

2.3.4 Chengdu Institute Japanese Encephalitis Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Liaoning Dacheng

2.4.1 Liaoning Dacheng Details

2.4.2 Liaoning Dacheng Major Business

2.4.3 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product and Services

2.4.4 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 Wuhan Institute

2.5.1 Wuhan Institute Details

2.5.2 Wuhan Institute Major Business

2.5.3 Wuhan Institute Japanese Encephalitis Virus Vaccine Product and Services

2.5.4 Wuhan Institute Japanese Encephalitis Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Japanese Encephalitis Virus Vaccine Breakdown Data by Manufacturer

3.1 Global Japanese Encephalitis Virus Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Japanese Encephalitis Virus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Japanese Encephalitis Virus Vaccine

3.4 Market Concentration Rate

3.4.1 Top 3 Japanese Encephalitis Virus Vaccine Manufacturer Market Share in 2021

3.4.2 Top 6 Japanese Encephalitis Virus Vaccine Manufacturer Market Share in 2021

3.5 Global Japanese Encephalitis Virus Vaccine Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Japanese Encephalitis Virus Vaccine Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Japanese Encephalitis Virus Vaccine Market Size by Region

4.1.1 Global Japanese Encephalitis Virus Vaccine Sales in Volume by Region (2017-2028)

4.1.2 Global Japanese Encephalitis Virus Vaccine Revenue by Region (2017-2028)

4.2 North America Japanese Encephalitis Virus Vaccine Revenue (2017-2028)

4.3 Europe Japanese Encephalitis Virus Vaccine Revenue (2017-2028)

4.4 Asia-Pacific Japanese Encephalitis Virus Vaccine Revenue (2017-2028)

4.5 South America Japanese Encephalitis Virus Vaccine Revenue (2017-2028)

4.6 Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Japanese Encephalitis Virus Vaccine Sales in Volume by Type (2017-2028)

5.2 Global Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2028)

5.3 Global Japanese Encephalitis Virus Vaccine Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Japanese Encephalitis Virus Vaccine Sales in Volume by Application (2017-2028)

6.2 Global Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2028)

6.3 Global Japanese Encephalitis Virus Vaccine Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Japanese Encephalitis Virus Vaccine Sales by Type (2017-2028)

7.2 North America Japanese Encephalitis Virus Vaccine Sales by Application (2017-2028)

7.3 North America Japanese Encephalitis Virus Vaccine Market Size by Country

7.3.1 North America Japanese Encephalitis Virus Vaccine Sales in Volume by Country (2017-2028)

7.3.2 North America Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Japanese Encephalitis Virus Vaccine Sales by Type (2017-2028)

8.2 Europe Japanese Encephalitis Virus Vaccine Sales by Application (2017-2028)

8.3 Europe Japanese Encephalitis Virus Vaccine Market Size by Country

8.3.1 Europe Japanese Encephalitis Virus Vaccine Sales in Volume by Country (2017-2028)

8.3.2 Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Type (2017-2028)

9.2 Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Application (2017-2028)

9.3 Asia-Pacific Japanese Encephalitis Virus Vaccine Market Size by Region

9.3.1 Asia-Pacific Japanese Encephalitis Virus Vaccine Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Japanese Encephalitis Virus Vaccine Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Japanese Encephalitis Virus Vaccine Sales by Type (2017-2028)

10.2 South America Japanese Encephalitis Virus Vaccine Sales by Application (2017-2028)

10.3 South America Japanese Encephalitis Virus Vaccine Market Size by Country

10.3.1 South America Japanese Encephalitis Virus Vaccine Sales in Volume by Country (2017-2028)

10.3.2 South America Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Japanese Encephalitis Virus Vaccine Sales by Type (2017-2028)

11.2 Middle East & Africa Japanese Encephalitis Virus Vaccine Sales by Application (2017-2028)

11.3 Middle East & Africa Japanese Encephalitis Virus Vaccine Market Size by Country

11.3.1 Middle East & Africa Japanese Encephalitis Virus Vaccine Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Japanese Encephalitis Virus Vaccine and Key Manufacturers

12.2 Manufacturing Costs Percentage of Japanese Encephalitis Virus Vaccine

12.3 Japanese Encephalitis Virus Vaccine Production Process

12.4 Japanese Encephalitis Virus Vaccine Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Japanese Encephalitis Virus Vaccine Typical Distributors

13.3 Japanese Encephalitis Virus Vaccine Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Japanese Encephalitis Virus Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Japanese Encephalitis Virus Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Research Foundation for Microbial Diseases of Osaka University Basic Information, Manufacturing Base and Competitors

Table 4. Research Foundation for Microbial Diseases of Osaka University Major Business

Table 5. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product and Services

Table 6. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Valneva Austria GmbH Basic Information, Manufacturing Base and Competitors

Table 8. Valneva Austria GmbH Major Business

Table 9. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product and Services

Table 10. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. Chengdu Institute Basic Information, Manufacturing Base and Competitors

Table 12. Chengdu Institute Major Business

Table 13. Chengdu Institute Japanese Encephalitis Virus Vaccine Product and Services

Table 14. Chengdu Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Liaoning Dacheng Basic Information, Manufacturing Base and Competitors

Table 16. Liaoning Dacheng Major Business

Table 17. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product and Services

Table 18. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Wuhan Institute Basic Information, Manufacturing Base and Competitors

Table 20. Wuhan Institute Major Business

Table 21. Wuhan Institute Japanese Encephalitis Virus Vaccine Product and Services

Table 22. Wuhan Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. Global Japanese Encephalitis Virus Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)

Table 24. Global Japanese Encephalitis Virus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 25. Market Position of Manufacturers in Japanese Encephalitis Virus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 26. Global Japanese Encephalitis Virus Vaccine Production Capacity by Company, (K Units): 2020 VS 2021

Table 27. Head Office and Japanese Encephalitis Virus Vaccine Production Site of Key Manufacturer

Table 28. Japanese Encephalitis Virus Vaccine New Entrant and Capacity Expansion Plans

Table 29. Japanese Encephalitis Virus Vaccine Mergers & Acquisitions in the Past Five Years

Table 30. Global Japanese Encephalitis Virus Vaccine Sales by Region (2017-2022) & (K Units)

Table 31. Global Japanese Encephalitis Virus Vaccine Sales by Region (2023-2028) & (K Units)

Table 32. Global Japanese Encephalitis Virus Vaccine Revenue by Region (2017-2022) & (USD Million)

Table 33. Global Japanese Encephalitis Virus Vaccine Revenue by Region (2023-2028) & (USD Million)

Table 34. Global Japanese Encephalitis Virus Vaccine Sales by Type (2017-2022) & (K Units)

Table 35. Global Japanese Encephalitis Virus Vaccine Sales by Type (2023-2028) & (K Units)

Table 36. Global Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2022) & (USD Million)

Table 37. Global Japanese Encephalitis Virus Vaccine Revenue by Type (2023-2028) & (USD Million)

Table 38. Global Japanese Encephalitis Virus Vaccine Price by Type (2017-2022) & (USD/Unit)

Table 39. Global Japanese Encephalitis Virus Vaccine Price by Type (2023-2028) & (USD/Unit)

Table 40. Global Japanese Encephalitis Virus Vaccine Sales by Application (2017-2022) & (K Units)

Table 41. Global Japanese Encephalitis Virus Vaccine Sales by Application (2023-2028) & (K Units)

Table 42. Global Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2022) & (USD Million)

Table 43. Global Japanese Encephalitis Virus Vaccine Revenue by Application (2023-2028) & (USD Million)

Table 44. Global Japanese Encephalitis Virus Vaccine Price by Application (2017-2022) & (USD/Unit)

Table 45. Global Japanese Encephalitis Virus Vaccine Price by Application (2023-2028) & (USD/Unit)

Table 46. North America Japanese Encephalitis Virus Vaccine Sales by Country (2017-2022) & (K Units)

Table 47. North America Japanese Encephalitis Virus Vaccine Sales by Country (2023-2028) & (K Units)

Table 48. North America Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2022) & (USD Million)

Table 49. North America Japanese Encephalitis Virus Vaccine Revenue by Country (2023-2028) & (USD Million)

Table 50. North America Japanese Encephalitis Virus Vaccine Sales by Type (2017-2022) & (K Units)

Table 51. North America Japanese Encephalitis Virus Vaccine Sales by Type (2023-2028) & (K Units)

Table 52. North America Japanese Encephalitis Virus Vaccine Sales by Application (2017-2022) & (K Units)

Table 53. North America Japanese Encephalitis Virus Vaccine Sales by Application (2023-2028) & (K Units)

Table 54. Europe Japanese Encephalitis Virus Vaccine Sales by Country (2017-2022) & (K Units)

Table 55. Europe Japanese Encephalitis Virus Vaccine Sales by Country (2023-2028) & (K Units)

Table 56. Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2022) & (USD Million)

Table 57. Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2023-2028) & (USD Million)

Table 58. Europe Japanese Encephalitis Virus Vaccine Sales by Type (2017-2022) & (K Units)

Table 59. Europe Japanese Encephalitis Virus Vaccine Sales by Type (2023-2028) & (K Units)

Table 60. Europe Japanese Encephalitis Virus Vaccine Sales by Application (2017-2022) & (K Units)

Table 61. Europe Japanese Encephalitis Virus Vaccine Sales by Application (2023-2028) & (K Units)

Table 62. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Region (2017-2022) & (K Units)

Table 63. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Region (2023-2028) & (K Units)

Table 64. Asia-Pacific Japanese Encephalitis Virus Vaccine Revenue by Region (2017-2022) & (USD Million)

Table 65. Asia-Pacific Japanese Encephalitis Virus Vaccine Revenue by Region (2023-2028) & (USD Million)

Table 66. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Type (2017-2022) & (K Units)

Table 67. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Type (2023-2028) & (K Units)

Table 68. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Application (2017-2022) & (K Units)

Table 69. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Application (2023-2028) & (K Units)

Table 70. South America Japanese Encephalitis Virus Vaccine Sales by Country (2017-2022) & (K Units)

Table 71. South America Japanese Encephalitis Virus Vaccine Sales by Country (2023-2028) & (K Units)

Table 72. South America Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2022) & (USD Million)

Table 73. South America Japanese Encephalitis Virus Vaccine Revenue by Country (2023-2028) & (USD Million)

Table 74. South America Japanese Encephalitis Virus Vaccine Sales by Type (2017-2022) & (K Units)

Table 75. South America Japanese Encephalitis Virus Vaccine Sales by Type (2023-2028) & (K Units)

Table 76. South America Japanese Encephalitis Virus Vaccine Sales by Application (2017-2022) & (K Units)

Table 77. South America Japanese Encephalitis Virus Vaccine Sales by Application (2023-2028) & (K Units)

Table 78. Middle East & Africa Japanese Encephalitis Virus Vaccine Sales by Region (2017-2022) & (K Units)

Table 79. Middle East & Africa Japanese Encephalitis Virus Vaccine Sales by Region (2023-2028) & (K Units)

Table 80. Middle East & Africa Japanese Encephalitis Virus Vaccine Revenue by Region (2017-2022) & (USD Million)

Table 81. Middle East & Africa Japanese Encephalitis Virus Vaccine Revenue by Region (2023-2028) & (USD Million)

Table 82. Middle East & Africa Japanese Encephalitis Virus Vaccine Sales by Type (2017-2022) & (K Units)

Table 83. Middle East & Africa Japanese Encephalitis Virus Vaccine Sales by Type (2023-2028) & (K Units)

Table 84. Middle East & Africa Japanese Encephalitis Virus Vaccine Sales by Application (2017-2022) & (K Units)

Table 85. Middle East & Africa Japanese Encephalitis Virus Vaccine Sales by Application (2023-2028) & (K Units)

Table 86. Japanese Encephalitis Virus Vaccine Raw Material

Table 87. Key Manufacturers of Japanese Encephalitis Virus Vaccine Raw Materials

Table 88. Direct Channel Pros & Cons

Table 89. Indirect Channel Pros & Cons

Table 90. Japanese Encephalitis Virus Vaccine Typical Distributors

Table 91. Japanese Encephalitis Virus Vaccine Typical Customers

List of Figures

Figure 1. Japanese Encephalitis Virus Vaccine Picture

Figure 2. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type in 2021

Figure 3. Inactivated Vaccine

Figure 4. Live Attenuated Vaccine

Figure 5. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application in 2021

Figure 6. Public

Figure 7. Private

Figure 8. Global Japanese Encephalitis Virus Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028

Figure 9. Global Japanese Encephalitis Virus Vaccine Revenue and Forecast (2017-2028) & (USD Million)

Figure 10. Global Japanese Encephalitis Virus Vaccine Sales (2017-2028) & (K Units)

Figure 11. Global Japanese Encephalitis Virus Vaccine Price (2017-2028) & (USD/Unit)

Figure 12. Global Japanese Encephalitis Virus Vaccine Production Capacity (2017-2028) & (K Units)

Figure 13. Global Japanese Encephalitis Virus Vaccine Production Capacity by Geographic Region: 2022 VS 2028

Figure 14. Japanese Encephalitis Virus Vaccine Market Drivers

Figure 15. Japanese Encephalitis Virus Vaccine Market Restraints

Figure 16. Japanese Encephalitis Virus Vaccine Market Trends

Figure 17. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Manufacturer in 2021

Figure 18. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Manufacturer in 2021

Figure 19. Japanese Encephalitis Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 20. Top 3 Japanese Encephalitis Virus Vaccine Manufacturer (Revenue) Market Share in 2021

Figure 21. Top 6 Japanese Encephalitis Virus Vaccine Manufacturer (Revenue) Market Share in 2021

Figure 22. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2017-2028)

Figure 23. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2017-2028)

Figure 24. North America Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (USD Million)

Figure 25. Europe Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (USD Million)

Figure 26. Asia-Pacific Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (USD Million)

Figure 27. South America Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (USD Million)

Figure 28. Middle East & Africa Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (USD Million)

Figure 29. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2017-2028)

Figure 30. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2017-2028)

Figure 31. Global Japanese Encephalitis Virus Vaccine Price by Type (2017-2028) & (USD/Unit)

Figure 32. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2017-2028)

Figure 33. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2017-2028)

Figure 34. Global Japanese Encephalitis Virus Vaccine Price by Application (2017-2028) & (USD/Unit)

Figure 35. North America Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2017-2028)

Figure 36. North America Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2017-2028)

Figure 37. North America Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2017-2028)

Figure 38. North America Japanese Encephalitis Virus Vaccine Revenue Market Share by Country (2017-2028)

Figure 39. United States Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 40. Canada Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 41. Mexico Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Europe Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2017-2028)

Figure 43. Europe Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2017-2028)

Figure 44. Europe Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2017-2028)

Figure 45. Europe Japanese Encephalitis Virus Vaccine Revenue Market Share by Country (2017-2028)

Figure 46. Germany Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. France Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. United Kingdom Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Russia Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Italy Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2017-2028)

Figure 52. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2017-2028)

Figure 53. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2017-2028)

Figure 54. Asia-Pacific Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2017-2028)

Figure 55. China Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Japan Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Korea Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. India Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Southeast Asia Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Australia Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. South America Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2017-2028)

Figure 62. South America Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2017-2028)

Figure 63. South America Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2017-2028)

Figure 64. South America Japanese Encephalitis Virus Vaccine Revenue Market Share by Country (2017-2028)

Figure 65. Brazil Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Argentina Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Middle East & Africa Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2017-2028)

Figure 68. Middle East & Africa Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2017-2028)

Figure 69. Middle East & Africa Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2017-2028)

Figure 70. Middle East & Africa Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2017-2028)

Figure 71. Turkey Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Egypt Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Saudi Arabia Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. South Africa Japanese Encephalitis Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Manufacturing Cost Structure Analysis of Japanese Encephalitis Virus Vaccine in 2021

Figure 76. Manufacturing Process Analysis of Japanese Encephalitis Virus Vaccine

Figure 77. Japanese Encephalitis Virus Vaccine Industrial Chain

Figure 78. Sales Channel: Direct Channel vs Indirect Channel

Figure 79. Methodology

Figure 80. Research Process and Data Source